Texas 2025 89th Regular

Texas House Bill HB2283 Fiscal Note / Fiscal Note

Filed 03/27/2025

                    LEGISLATIVE BUDGET BOARD     Austin, Texas       FISCAL NOTE, 89TH LEGISLATIVE REGULAR SESSION             March 27, 2025       TO: Honorable Gary VanDeaver, Chair, House Committee on Public Health     FROM: Jerry McGinty, Director, Legislative Budget Board      IN RE: HB2283 by Cortez (Relating to the use of an epinephrine delivery device by certain entities.), As Introduced     No significant fiscal implication to the State is anticipated. It is assumed that any costs associated with the bill could be absorbed using existing resources.  Local Government ImpactNo significant fiscal implication to units of local government is anticipated.  Source Agencies: b > td > 405 Department of Public Safety, 407 Commission on Law Enforcement, 503 Texas Medical Board, 515 Board of Pharmacy, 529 Health and Human Services Commission, 537 State Health Services, Department of, 701 Texas Education Agency, 710 Texas A&M University System Administrative and General Offices, 720 The University of Texas System Administration  LBB Staff: b > td > JMc, NPe, JPE, THO, NAz

LEGISLATIVE BUDGET BOARD
Austin, Texas
FISCAL NOTE, 89TH LEGISLATIVE REGULAR SESSION
March 27, 2025

 

 

  TO: Honorable Gary VanDeaver, Chair, House Committee on Public Health     FROM: Jerry McGinty, Director, Legislative Budget Board      IN RE: HB2283 by Cortez (Relating to the use of an epinephrine delivery device by certain entities.), As Introduced   

TO: Honorable Gary VanDeaver, Chair, House Committee on Public Health
FROM: Jerry McGinty, Director, Legislative Budget Board
IN RE: HB2283 by Cortez (Relating to the use of an epinephrine delivery device by certain entities.), As Introduced

 Honorable Gary VanDeaver, Chair, House Committee on Public Health

 Honorable Gary VanDeaver, Chair, House Committee on Public Health

 Jerry McGinty, Director, Legislative Budget Board 

 Jerry McGinty, Director, Legislative Budget Board 

 HB2283 by Cortez (Relating to the use of an epinephrine delivery device by certain entities.), As Introduced 

 HB2283 by Cortez (Relating to the use of an epinephrine delivery device by certain entities.), As Introduced 



No significant fiscal implication to the State is anticipated.

No significant fiscal implication to the State is anticipated.

It is assumed that any costs associated with the bill could be absorbed using existing resources.

 Local Government Impact

No significant fiscal implication to units of local government is anticipated.

Source Agencies: b > td > 405 Department of Public Safety, 407 Commission on Law Enforcement, 503 Texas Medical Board, 515 Board of Pharmacy, 529 Health and Human Services Commission, 537 State Health Services, Department of, 701 Texas Education Agency, 710 Texas A&M University System Administrative and General Offices, 720 The University of Texas System Administration

405 Department of Public Safety, 407 Commission on Law Enforcement, 503 Texas Medical Board, 515 Board of Pharmacy, 529 Health and Human Services Commission, 537 State Health Services, Department of, 701 Texas Education Agency, 710 Texas A&M University System Administrative and General Offices, 720 The University of Texas System Administration

LBB Staff: b > td > JMc, NPe, JPE, THO, NAz

JMc, NPe, JPE, THO, NAz